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Prevalence of type 2 diabetes (T2D) has been increasing glob-
ally, gaining high public health priority [1]. T2D is a complex
disease, resulting from an interplay between lifestyle and
genetic factors. Evidence from several randomized controlled
trials suggests that physical activity and dietary intervention
could prevent or delay progression of T2D [2–4]. In addition,
genome-wide association studies have identified hundreds
of genetic variants associated with T2D [5]. In the present
special issue, each paper investigated different aspects of
T2D prevention strategy, ranging from physical activity and
diet/nutritional biomarker to gene-epigenetic mechanisms,
in animal models and human studies.
J. Qi et al. revealed that, in rats with insulin resistance
induced by a high-fat diet, swimming exercise could improve
insulin sensitivity, potentially via a reduction of TRIM72
expression, and upregulation of PI3-K/AKT signaling path-
way, including IRS-1, p-AKTSer473, and AKT expression. The
PI3-K/AKT signaling pathway is critically important for the
regulation of insulin sensitivity and other biological processes
related to aging [6, 7]. This study further showcased the
intricate mechanism linking physical activity (swimming in
this study) to insulin resistance.With similar design in a high-
fat induced nonalcoholic fatty liver disease rodent model, Y.
Xie et al. found that total alkaloid from Nelumbinis Plumula
(NPA) could reduce insulin resistance via mechanism of
restoring IRS1 and suppressing the JNK phosphorylation.
Indeed, natural products derived from food resources have
been proved to be promising natural remedies for T2D
prevention and treatment [8].
Objectively measured nutritional biomarker may over-
come recall bias and measurement error resulting from
traditional dietary assessment tools, such as food frequency
questionnaires. Emergingmetabolomics studies are revealing
more andmore promising nutritional biomarkers and linking
them to health outcomes. One of the examples is Branched-
Chain Amino Acid (BCAA). In this issue, X. Zhao et al. sys-
tematically reviewed the current evidence on the relationship
between BCAA and insulin resistance and concluded that
circulating BCAAs (including valine, leucine, and isoleucine)
are positively associated with insulin resistance and are useful
biomarkers to predict futureT2Dcases. In a recentMendelian
randomization analysis, researchers identified a causal asso-
ciation of high circulating BCAAs with T2D risk and proved
the causal role of BCAAmetabolism in the T2D etiology [9].
Thus, use of nutritional biomarkers has obtained increasing
popularity given their nature of objective measurement and
potential usage to test causality in observational studies.
Lastly, L. Yang et al. updated the association of genetic
variations in LEPR gene with T2D risk with a meta-analysis,
providing robust evidence for the association between
rs1137101 at LEPR and T2D risk. In addition, T. Matsha et
al. demonstrated the role of DNA methylation-genetic vari-
ations in screen-detected diabetes or known diabetes on
treatment in an African population. All the above efforts add
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to the current knowledge on the role of genetic and epigenetic
modulation on T2D etiology [10].
Taken together, articles in this special issue highlight
several important fields in the prevention and treatment of
T2D, focusing on the important role of diet and physical
activity, incorporating natural remedies from food resources
and new omics (metabolomics and genomics) strategies. The
issue also suggests the importance of integrative strategies for
the prevention and treatment of T2D in future research.
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